Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New stent study aims to keep heart arteries open in routine care

NCT ID NCT03588481

Disease control Sponsor: Seung-Jung Park Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is tracking 1,000 people who receive the DESyne X2 drug-eluting stent to treat narrowed or blocked coronary arteries. Researchers are monitoring how often patients experience serious heart events like death, heart attack, or the need for another procedure. The goal is to see how well the stent works in everyday hospital settings.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
DESyne X2 drug-eluting coronary stent (novolimus-eluting stent)
What this could lead to
If successful, this study could confirm that the DESyne X2 stent is safe and effective for treating blocked coronary arteries in everyday medical practice.
What could go wrong
This is an observational study, not a controlled trial, so results may be influenced by patient selection or other factors. The stent is already approved, so this is about real-world performance, not a breakthrough.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 1,000 people

The number the study aims to enrol. It can still change while the study runs.

Started

Nov 2018

Expected to finish

Dec 2031

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

patients with DeSyne X2 stent

Ages

19 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age 19 and more * Intervention with DeSyne X2 drug-eluting coronary stent * Agreed with written informed consent form Exclusion Criteria: * Intervention with DeSyne X2 drug-eluting coronary stent and other drug eluting stent at the same time * Life expectancy of 1year and under * Cardiac shock

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Coronary disease are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

coronary artery disorder Coronary Disease Coronary Occlusion coronary stenosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Coronary disease Coronary occlusion Coronary stenosis

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Asan Medical Hospital

    RECRUITING

    Seoul, South Korea

  • Hallym Hospital

    RECRUITING

    Incheon, South Korea

  • Korea University Guro Hospital

    TERMINATED

    Seoul, South Korea

  • St.carollo Hospital

    TERMINATED

    Suncheon, South Korea

  • The Catholic University of Korea Seoul St. Mary's Hospital

    WITHDRAWN

    Seoul, South Korea

  • The Catholic University of Korea, Eunpyeong St. Mary's Hospital

    TERMINATED

    Seoul, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.